重药控股：关于回购股份进展的公告

Group 1 - The company, Chongqing Pharmaceutical Holdings, announced that as of January 31, 2026, it has repurchased a total of 15,406,600 shares through a dedicated securities account via centralized bidding, which represents approximately 0.8915% of the company's total share capital [2]